Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
T Cells
Biotech
Gilead bets $1.5B-plus on Merus' trispecifc T-cell engagers
Gilead is joining the likes of Amgen and Merck by heading deeper into the T-cell engager space.
Max Bayer
Mar 6, 2024 10:02am
Using cancer's 'superpower' to boost T-cell therapies in mice
Feb 12, 2024 3:30pm
Elicio vaccine boosts T-cell therapy response to tumors in mice
Jan 29, 2024 10:53am
Chromosome loss from CRISPR-Cas9 stopped by swapping steps
Oct 9, 2023 7:40am
Using DNA origami to make T-cell therapies more precise
Aug 21, 2023 4:00pm
Amgen's tarlatamab BiTEs at SCLC in brief readout
Aug 3, 2023 4:01pm